These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9374377)

  • 1. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
    Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
    Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
    Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
    Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.
    Rosier JF; Bruniaux M; Husson B; Octave-Prignot M; Beauduin M; Grégoire V
    Radiother Oncol; 2004 Jan; 70(1):55-61. PubMed ID: 15036853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
    Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-joining deficiency and radiosensitization induced by gemcitabine.
    van Putten JWG ; Groen HJM ; Smid K; Peters GJ; Kampinga HH
    Cancer Res; 2001 Feb; 61(4):1585-91. PubMed ID: 11245469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
    Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
    Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing therapeutic gain with gemcitabine and fractionated radiation.
    Mason KA; Milas L; Hunter NR; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang KK
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1125-35. PubMed ID: 10421547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of homologous DNA recombination repair by gemcitabine.
    Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
    Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
    Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
    Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
    Grégoire V; Rosier JF; De Bast M; Bruniaux M; De Coster B; Octave-Prignot M; Scalliet P
    Radiother Oncol; 2002 Jun; 63(3):329-38. PubMed ID: 12142097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gemcitabine on the tolerance of the lung to single-dose irradiation in C3H mice.
    Grégoire V; Cvilic S; Beauduin M; De Coster B; Gueulette J; Octave-Prignot M; Scalliet P
    Radiat Res; 1999 Jun; 151(6):747-9. PubMed ID: 10360795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.
    Weiss C; Grabenbauer GG; Sauer R; Distel L
    Strahlenther Onkol; 2003 Feb; 179(2):93-8. PubMed ID: 12590319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.
    Rosier JF; Beauduin M; Bruniaux M; de Bast M; de Coster B; Octave-Prignot M; Scalliet P; Grégoire V
    Int J Radiat Biol; 1999 Feb; 75(2):245-51. PubMed ID: 10072186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tumor radioresponse in vivo by gemcitabine.
    Milas L; Fujii T; Hunter N; Elshaikh M; Mason K; Plunkett W; Ang KK; Hittelman W
    Cancer Res; 1999 Jan; 59(1):107-14. PubMed ID: 9892194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle effects of gemcitabine.
    Cappella P; Tomasoni D; Faretta M; Lupi M; Montalenti F; Viale F; Banzato F; D'Incalci M; Ubezio P
    Int J Cancer; 2001 Aug; 93(3):401-8. PubMed ID: 11433406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
    Ostruszka LJ; Shewach DS
    Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine as a radiosensitizer in undifferentiated tumors.
    Kal HB; El Sharouni SY; Barten-van Rijbroek AD
    Anticancer Res; 2006; 26(1A):139-45. PubMed ID: 16475690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
    Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
    Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro.
    Rockwell S; Grindey GB
    Oncol Res; 1992; 4(4-5):151-5. PubMed ID: 1504375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.